This is a reflection of a paradigm shift in the cancer field as it comes to phosphatases, including SHIP2.135 Phosphatases were earlier considered rather as tumour suppressors, but the finding that they can activate signalling pathways proposes that they could actually be potential oncogenes and thereby targets for cancer treatment. This evidence concerns the gene INPPL1 and cancer.